The influence of host factors on cyclophosphamide treatment of Moloney virus-induced lymphomas.
D000818:Animals; D000906:Antibodies; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D007108:Immune Tolerance; D008223:Lymphoma / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D051379:Mice; D008979:Moloney murine leukemia virus / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011830:Radiation Effects
D000906:Antibodies; D003520:Cyclophosphamide